Literature DB >> 17275091

An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.

Anshul Gupte1, Russell J Mumper.   

Abstract

D-Penicillamine is a potent copper (Cu) chelating agent. D-Pen reduces Cu(II) to Cu(I) in the process of chelation while at the same time being oxidized to D-penicillamine disulfide. It has been proposed that hydrogen peroxide is generated during this process. However, definitive experimental proof that hydrogen peroxide is generated remains lacking. Thus, the major aims of these studies were to confirm and quantitatively assess the in vitro production of hydrogen peroxide during copper catalyzed D-penicillamine oxidation. The potential cytotoxic effect of hydrogen peroxide generation was also investigated in vitro against MCF-7 human breast cancer cells. Cell cytotoxicity resulting from the incubation of D-penicillamine with copper was compared to that of D-penicillamine, copper and hydrogen peroxide. The mechanism of copper catalyzed D-penicillamine oxidation and simultaneous hydrogen peroxide production was investigated as a function of time, concentration of cupric sulfate or ferric chloride, temperature, pH, anaerobic condition and chelators such as ethylenediaminetetraacetic acid and bathocuproinedisulfonic acid. A simple, sensitive and rapid HPLC assay was developed to simultaneously detect D-penicillamine, its major oxidation product D-penicillamine disulfide, and hydrogen peroxide in a single run. Hydrogen peroxide was shown to be generated in a concentration dependent manner as a result of D-penicillamine oxidation in the presence of cupric sulfate. Chelators such as ethylenediaminetetraacetic acid and bathocuproinedisulfonic acid were able to inhibit D-penicillamine oxidation. The incubation of MCF-7 human breast cancer cells with D-penicillamine plus cupric sulfate resulted in the production of reactive oxygen species within the cell and cytotoxicity that was comparable to free hydrogen peroxide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17275091     DOI: 10.1016/j.jinorgbio.2006.12.007

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  10 in total

1.  Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper.

Authors:  Kelly C Falls-Hubert; Aimee L Butler; Kai Gui; Michael Anderson; Mengshi Li; Jeffrey M Stolwijk; Samuel N Rodman; Shane R Solst; Ann Tomanek-Chalkley; Charles C Searby; Val C Sheffield; Vanessa Sandfort; Hartmut Schmidt; Michael L McCormick; Brian R Wels; Bryan G Allen; Garry R Buettner; Michael K Schultz; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2020-02-04       Impact factor: 7.376

2.  D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H2O2-mediated oxidative stress.

Authors:  Sebastian J Sciegienka; Shane R Solst; Kelly C Falls; Joshua D Schoenfeld; Adrienne R Klinger; Natalie L Ross; Samuel N Rodman; Douglas R Spitz; Melissa A Fath
Journal:  Free Radic Biol Med       Date:  2017-04-05       Impact factor: 7.376

3.  Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15-18 October 2017; Cancun, Mexico.

Authors:  Kelly C Falls; Ricky A Sharma; Yaacov R Lawrence; Richard A Amos; Sunil J Advani; Mansoor M Ahmed; Bhadrasain Vikram; C Norman Coleman; Pataje G Prasanna
Journal:  Radiat Res       Date:  2018-10       Impact factor: 2.841

4.  D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis.

Authors:  Shuxi Qiao; Christopher M Cabello; Sarah D Lamore; Jessica L Lesson; Georg T Wondrak
Journal:  Apoptosis       Date:  2012-10       Impact factor: 4.677

5.  Biocompatible D-Penicillamine Conjugated Au Nanoparticles: Targeting Intracellular Free Copper Ions for Detoxification.

Authors:  Murthi S Kandanapitiye; Chamila Gunathilake; Mietek Jaroniec; Songping D Huang
Journal:  J Mater Chem B       Date:  2015-07-21       Impact factor: 6.331

6.  Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure.

Authors:  Dingbang Chen; Xiangxue Zhou; Haiman Hou; Li Feng; JunXiu Liu; Yinyin Liang; Xiaopu Lin; Jiwei Zhang; Chao Wu; Xiuling Liang; Zhong Pei; Xunhua Li
Journal:  Ther Adv Neurol Disord       Date:  2016-04-07       Impact factor: 6.570

7.  In vitro reactive oxygen species production by histatins and copper(I,II).

Authors:  Eric A Houghton; Kenneth M Nicholas
Journal:  J Biol Inorg Chem       Date:  2008-10-31       Impact factor: 3.358

8.  Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism.

Authors:  Steven R Hall; Heather L Blundon; Matthew A Ladda; Andrew W Robertson; Camilo F Martinez-Farina; David L Jakeman; Kerry B Goralski
Journal:  Pharmacol Res Perspect       Date:  2015-03

9.  Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients.

Authors:  Meghri Katerji; Kassem Barada; Mustapha Jomaa; Firas Kobeissy; Ahmad-Kareem Makkawi; Wassim Abou-Kheir; Julnar Usta
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

Review 10.  Copper-lowering agents as an adjuvant in chemotherapy.

Authors:  Pramod Kadu; Bhakti Sawant; Pravin Popatrao Kale; Kedar Prabhavalkar
Journal:  Indian J Pharmacol       Date:  2021 May-Jun       Impact factor: 1.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.